TRAPPC4
Basic information
Region (hg38): 11:119018763-119025454
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy (Definitive), mode of inheritance: AR
- syndromic intellectual disability (Supportive), mode of inheritance: AD
- neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy (Limited), mode of inheritance: AR
- neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy (Strong), mode of inheritance: AR
- neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 31794024 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (30 variants)
- not_provided (11 variants)
- Neurodevelopmental_disorder_with_epilepsy,_spasticity,_and_brain_atrophy (10 variants)
- EBV-positive_nodal_T-_and_NK-cell_lymphoma (1 variants)
- TRAPPC4-related_disorder (1 variants)
- Neurodevelopmental_disorder_with_progressive_microcephaly,_spasticity,_and_brain_anomalies (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRAPPC4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016146.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 37 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 2 | 38 | 1 | 2 |
Highest pathogenic variant AF is 0.000384545
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRAPPC4 | protein_coding | protein_coding | ENST00000533632 | 5 | 7023 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000412 | 0.394 | 125711 | 0 | 36 | 125747 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.428 | 106 | 119 | 0.890 | 0.00000526 | 1407 |
Missense in Polyphen | 36 | 43.975 | 0.81864 | 550 | ||
Synonymous | -2.49 | 69 | 47.2 | 1.46 | 0.00000218 | 446 |
Loss of Function | 0.448 | 9 | 10.6 | 0.851 | 5.49e-7 | 116 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000456 | 0.000456 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in vesicular transport from endoplasmic reticulum to Golgi.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Extracellular matrix organization;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Rab regulation of trafficking;Syndecan interactions;Non-integrin membrane-ECM interactions;RAB GEFs exchange GTP for GDP on RABs;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport;Syndecan-2-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- loftool
- 0.580
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 33.97
Haploinsufficiency Scores
- pHI
- 0.0542
- hipred
- Y
- hipred_score
- 0.576
- ghis
- 0.653
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.842
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trappc4
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;dendrite development;COPII vesicle coating
- Cellular component
- Golgi membrane;endoplasmic reticulum;Golgi stack;cytosol;synaptic vesicle;TRAPP complex;dendrite;synapse
- Molecular function
- protein binding;Rab guanyl-nucleotide exchange factor activity